申请人:Tosaki Shinya
公开号:US20130267532A1
公开(公告)日:2013-10-10
The invention concerns compounds of Formula (I): (I) and pharmaceutically acceptable salts thereof, wherein n, R
1
and R
2
are as defined in the description. The present invention also relates to processes for the preparation of such compounds, novel intermediates useful in the preparation of such compounds, pharmaceutical compositions containing them and their use in the treatment of disease, for example cancer.
本发明涉及公式(I)的化合物及其药学上可接受的盐,其中n、R1和R2如描述中所定义。本发明还涉及制备这种化合物的过程、制备这种化合物有用的新型中间体、含有它们的药物组合物以及它们在治疗疾病(例如癌症)中的应用。